Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects

    Greenfield, J. R., Farooqi, I. S., Keogh, J. M., Henning, E., Habib, A. M., Blackwood, A., Reimann, F., Holst, Jens Juul & Gribble, F. M., 2008, In: American Journal of Clinical Nutrition. 89, 1, p. 106-13 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects

    Enç, F. Y., Ones, T., Akin, H. L., Dede, F., Turoglu, H. T., Ulfer, G., Bekiroglu, N., Haklar, G., Rehfeld, Jens Frederik, Holst, Jens Juul, Ulusoy, N. B. & Imeryüz, N., 2008, In: American Journal of Physiology: Gastrointestinal and Liver Physiology. 296, 3, p. G482-9

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations

    Ellrichmann, M., Kapelle, M., Ritter, P. R., Holst, Jens Juul, Herzig, K. H., Schmidt, W. E., Schmitz, F. & Meier, J. J., 2008, In: Journal of Clinical Endocrinology and Metabolism. 93, 10, p. 3995-3998 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations

    Ellrichmann, M., Kapelle, M., Ritter, P. R., Holst, Jens Juul, Herzig, K., Schmidt, W. E., Schmitz, F. & Meier, J. J., Oct 2008, In: The Journal of clinical endocrinology and metabolism. 93, 10, p. 3995-8 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Overconsumption and obesity: peptides and susceptibility to weight gain

    Blundell, J. E., Levin, F., King, N. A., Barkeling, B., Gustafsson, T., Gustafson, T., Hellstrom, P. M., Holst, Jens Juul & Naslund, E., 7 Aug 2008, In: Regulatory Peptides. 149, 1-3, p. 32-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Overconsumption and obesity: Peptides and susceptibility to weight gain

    Blundell, J. E., Levin, F., King, N. A., Barkeling, B., Gustafson, T., Hellstrom, P. M., Holst, Jens Juul & Naslund, E., 2008, In: Regulatory Peptides. 149, 1-3, p. 32-38 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Overview of incretin hormones.

    Holst, Jens Juul & Lasalle, J., 2008, In: Journal of Family Practice. 57, 9, p. 53-59

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Plasma glucagon-like peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption.

    Valeur, J., Øines, E., Morken, M. H., Holst, Jens Juul & Berstad, A., 2008, In: Scandinavian Journal of Gastroenterology. 43, 10, p. 1212-8 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

    Vollmer, K., Holst, Jens Juul, Baher, B., Ellrichmann, M., Nauck, M. A., Schmidt, W. E. & Meier, J. J., 2008, In: Diabetes. 57, 3, p. 678-687 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Progression from normal glucose tolerance to impaired fasting glycaemia and impaired glucose tolerance: differential roles of insulin resistance and beta cell dysfunction

    Faerch, K., Vaag, Allan, Holst, Jens Juul, Pedersen, O., Glumer, C. & Borch-Johnsen, K., 2008, In: Diabetologia. 51, Suppl. 1, p. S85-S86

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207